Positive Phase-IIb-Ergebnisse bei Zweitlinienbehandlung von Melanomen

NEXT STORY
Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Combination with Pembrolizumab in Advanced Cancers at Society for Immunotherapy of Cancer (SITC) Annual Meeting
PREV STORY
Aadi Bioscience Presents Two Abstracts on FYARRO (nab-Sirolimus) at the Annual Meeting of the Connective Tissue Oncology Society (CTOS)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MediWound Announces Peer-Reviewed Publication of EscharEx In-Vivo Head-to-Head Comparator Study in the Journal of Wound Care

author_avatar
NASDAQ Market News

Global OTC/DTC Infectious Disease Diagnostics Market Strategies and Trends Report 2020: COVID-19 Creates New Direct to Consumer Diagnostics Opportunities

author_avatar
NASDAQ Market News

Mereo BioPharma Announces Completion of $70 Million Private Placement

author_avatar
NASDAQ Market News